Medical Devices & Diagnostics
Quality & Compliance Services
Build Trust. Scale Faster. Stay Compliant.
Medical device and diagnostics regulations differ substantially from those governing pharmaceuticals, shaping how products are designed, developed, manufactured, and maintained throughout their lifecycle. At ProPharma, we bring a dedicated team focused exclusively on medical devices and diagnostics, with the experience of navigating these unique regulatory expectations and the practical realities of bringing products to market.
Quality systems are the foundation of what we do, but our support does not stop there. We help clients design, implement, and manage effective Quality Management Systems, while also supporting the strategic, operational, and remediation activities required to sustain compliance across the full product lifecycle. From early feasibility through design controls application into global commercialization and post-market oversight, we translate regulatory requirements into efficient, defensible, and business-aligned solutions.
We support medical device and diagnostics companies operating in both the US and international markets, with deep expertise in FDA regulations, ISO 13485, MDSAP, EU MDR, and IVDR. Our team understands how quality, regulatory, and operational decisions intersect—and how to build systems and processes that not only meet compliance expectations but also enable innovation, speed, and sustainable growth.
By aligning quality with your business objectives, we help you:
- Reduce regulatory risk while accelerating market access
- Build scalable systems that grow with your product portfolio
- Prepare for submissions, inspections, and audits with confidence
- Respond effectively to regulatory challenges without disrupting operations
Build & Scale Quality Systems
Create quality systems that grow with your business.
Building a strong quality foundation is critical for medical devices and diagnostics companies, particularly as products advance through development, scale into manufacturing, and enter global markets. We partner with clients to design, implement, and optimize Quality Management Systems that are fit for purpose, aligned with regulatory expectations, and capable of supporting long-term growth.
Speak with a Medical Device & Diagnostics ExpertOur approach recognizes that quality systems must do more than satisfy auditors. They must enable efficient execution, support design and development activities, manage supplier complexity, and adapt as products, technologies, and regulations evolve. With the FDA's transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR) and increased alignment with ISO 13485, many organizations are reassessing how their quality systems are structured, integrated, and governed. We help clients use this shift as an opportunity to streamline processes, eliminate redundancy, and build globally aligned systems.
We support organizations at all stages, from early-stage companies establishing their first QMS to mature manufacturers by modernizing or remediating existing systems. Our experts work closely with your team to ensure that quality systems are right-sized for your product, risk profile, and business objectives while remaining inspection-ready.
Build & Scale Capabilities Include
This foundation enables organizations to scale with confidence, reduce regulatory risk, and move efficiently through development, submission, and commercialization.
Quality Management Systems (QMS)
Designing, implementing, upgrading, and remediating QMS that are audit-ready, scalable, and aligned with FDA QMSR, ISO 13485, EU MDR/IVDR, and MDSAP expectations.
Design Quality & Risk Management
Embedding design controls, risk management (ISO 14971), human factors and usability engineering (IEC 62366-1), into product and process development to support safe, effective, and compliant devices.
Software & SaMD Lifecycle Compliance
Designing and implementing software development lifecycle (SDLC) governance frameworks aligned with global SaMD guidance. Establishing documentation architecture, configuration management, cybersecurity controls, and regulatory traceability to support compliant digital and software-enabled products.
Supplier Quality & External Partner Oversight
Establishing robust supplier qualification, oversight, auditing, and quality agreement frameworks for Contract Manufacturing Organizations (CMOs), laboratories, raw materials suppliers, and other critical partners.
IVD Quality Expertise
Addressing the unique quality and regulatory challenges associated with in vitro diagnostics, including companion diagnostics (CDx), point-of-care (POC), and at-home testing products.
Program & Project Management Support
Providing experienced medical device and diagnostics project management to launch new initiatives, realign existing programs, and ensure quality-related projects are executed effectively and sustainably.
Operate & Assure Compliance
Keep your quality system working for you.
Once a quality system is established, maintaining compliance requires ongoing oversight, disciplined execution, and continuous improvement. For medical device and diagnostics companies, this means ensuring that quality processes are consistently applied across operations, suppliers, and markets, while remaining adaptable to evolving regulatory expectations and business needs.
Speak with a Medical Device & Diagnostics ExpertWe help organizations operate and sustain effective quality systems that withstand inspections, support post-market obligations, and drive operational excellence. Our approach focuses on proactive monitoring, risk-based decision-making, and practical integration of quality into day-to-day operations. Rather than treating compliance as a periodic activity, we help embed it into how organizations work.
Operating in this phase often includes preparing for regulatory inspections, overseeing software and data-driven systems, and maintaining robust change management practices. Our experts partner with your team to strengthen these capabilities, identify emerging risks early, and address gaps before they escalate into compliance issues.
Operate & Assure Capabilities Include
Audits & Compliance Assessments
Executing and maintaining audit-ready quality systems through internal audits, supplier audits, inspection readiness activities, GxP audits, and pre-approval...
Read MoreAudits & Compliance Assessments
Executing and maintaining audit-ready quality systems through internal audits, supplier audits, inspection readiness activities, GxP audits, and pre-approval preparation.
Read LessData Quality
Supporting software lifecycle compliance, SaMD quality expectations, and validation of lab informatics and digital systems to ensure data integrity and inspection readiness.
Data Quality
Supporting software lifecycle compliance, SaMD quality expectations, and validation of lab informatics and digital systems to ensure data integrity and inspection readiness.
Read LessChange Management & Lifecycle Governance
Implementing Governing structured change control, design change assessment, and product lifecycle activities to ensure regulatory impact and risks areis...
Read MoreChange Management & Lifecycle Governance
Implementing Governing structured change control, design change assessment, and product lifecycle activities to ensure regulatory impact and risks areis assessed, documented, and controlled.
Read LessContinuous Improvement Mindset
Adopting an approach that focuses on delivering incremental enhancements that drive continuous improvement methods for sustaining product quality, increasing...
Read MoreContinuous Improvement Mindset
Adopting an approach that focuses on delivering incremental enhancements that drive continuous improvement methods for sustaining product quality, increasing productivity, reducing risk and maximizing profitability.
Read LessQuality Training & Organizational Enablement
Delivering role-based quality training, inspection readiness coaching, and organizational enablement to strengthen accountability, consistency, and...
Read MoreQuality Training & Organizational Enablement
Delivering role-based quality training, inspection readiness coaching, and organizational enablement to strengthen accountability, consistency, and sustained compliance.
Read LessRespond & Recover from Regulatory Challenges
When regulatory pressure strikes, move quickly and confidently.
Even the most mature quality systems can face regulatory challenges. Inspections, audits, and post-market events can surface issues that require rapid, well-coordinated responses, often under intense regulatory and business pressure. How an organization responds can significantly influence regulatory outcomes, product availability, and long-term credibility.
We support medical device and diagnostics companies through these regulatory situations, helping them respond with clarity, precision, and confidence. Our team brings hands-on experience addressing FDA 483 observations, warning letters, ISO nonconformances, Notified Body findings, and field actions across global markets. We work side-by-side with your organization to assess risk, develop defensible response strategies, and execute sustainable remediation.
Our approach goes beyond drafting responses. We help organizations identify root causes, implement effective CAPAs, and strengthen underlying systems to prevent recurrence. Whether responding to an inspection, or managing a complex remediation program, we focus on solutions that restore compliance while minimizing operational disruption.
Respond & Recover Capabilities Include
Through disciplined response and targeted remediation, we help clients stabilize compliance, protect their products and patients, and rebuild regulatory confidence.
Inspection & Notified Body Readiness
Preparing for FDA, EU, and global inspections through mock audits, interview investigator preparation, and war-room support to ensure your team is confident and inspection-ready.
Regulatory Response & Remediation
Developing and executing responses to FDA 483 observations, warning letters, ISO nonconformances, and Notified Body findings, while leading remediation initiatives including MDR and IVDR transitions and systemic quality improvements.
Field Action Support
Managing field actions (corrections, removals, or recalls), including root-cause analysis, corrective actions, and regulatory reporting to protect patients and maintain compliance.
Corrective & Preventive Actions (CAPA)
Providing end-to-end CAPA strategy, execution, and verification to address findings, prevent recurrence, and ensure sustainable compliance.
Why Partner with ProPharma
At ProPharma, we combine deep technical expertise, regulatory insight, and practical execution to help medical device and diagnostics companies navigate the complexities of quality and compliance. Our team brings hands-on experience across all stages of the product lifecycle, from early feasibility and design control through commercialization and remediation.
Partnering with us gives you:
- Regulatory confidence: FDA, EU MDR/IVDR, ISO 13485, and MDSAP expertise ensures your systems, processes, and responses are inspection-ready and globally aligned.
- Operational efficiency: Scalable, right-sized quality systems and processes that support innovation, minimize duplication, and integrate seamlessly with your operations.
- Risk mitigation and resilience: Proactive oversight, audits, and remediation programs that reduce regulatory risk and enable timely, defensible responses when issues arise.
- Full-lifecycle support: Expertise spanning Build & Scale, Operate & Assure, and Respond & Recover, so your organization is prepared for every stage of product development and commercialization.
- Practical, outcomes-focused guidance: Solutions designed not just for compliance, but to enable your business goals and accelerate time to market.
Why Partner with ProPharma
At ProPharma, we combine deep technical expertise, regulatory insight, and practical execution to help medical device and diagnostics companies navigate the complexities of quality and compliance. Our team brings hands-on experience across all stages of the product lifecycle, from early feasibility and design control through commercialization and remediation.
Partnering with us gives you:
- Regulatory confidence: FDA, EU MDR/IVDR, ISO 13485, and MDSAP expertise ensures your systems, processes, and responses are inspection-ready and globally aligned.
- Operational efficiency: Scalable, right-sized quality systems and processes that support innovation, minimize duplication, and integrate seamlessly with your operations.
- Risk mitigation and resilience: Proactive oversight, audits, and remediation programs that reduce regulatory risk and enable timely, defensible responses when issues arise.
- Full-lifecycle support: Expertise spanning Build & Scale, Operate & Assure, and Respond & Recover, so your organization is prepared for every stage of product development and commercialization.
- Practical, outcomes-focused guidance: Solutions designed not just for compliance, but to enable your business goals and accelerate time to market.
With ProPharma as your partner, you gain a team that bridges the gap between regulatory requirements and real-world operations, helping your organization build scalable quality systems, maintain consistent compliance, and respond decisively to challenges, all while keeping your products on the path totrack for market success.
News & Insights
March 9, 2026
Global Medical Information, Local Voices: Multilingual Contact Centers That Scal...
Discover how ProPharma's multilingual contact centers deliver consistent, accurate medical information globally, ensuring compliance and cultural alignment with over 35 languages.
March 3, 2026
ANDA Development Made Clear: Expert Advice on Submission Strategy, Labeling, and...
Learn how strategic reference product selection, patent navigation, and labeling alignment under the 505(j) pathway drive efficient, approval-ready ANDA submissions.
January 27, 2026
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...
ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.
December 11, 2025
ProPharma Expands Operations with New Office in Hyderabad
ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
March 13, 2026
Restoring Inspection Readiness and Building a Long-Term Pharmacovigilance Partne...
A mid-sized biotechnology company operating in the EU faced critical pharmacovigilance (PV) compliance findings following an inspection by the European Medicines Agency and Medicines and Healthcare...
February 5, 2026
Setting up a Global PV System
A company needed to rapidly establish a fully compliant global pharmacovigilance (PV) system, including UK/EU QPPV coverage, to meet regulatory requirements by a fixed deadline. With safety data and...
April 23, 2026
Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market
As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...
April 9, 2026
EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...
News & Insights
March 13, 2026
Restoring Inspection Readiness and Building a Long-Term Pharmacovigilance Partne...
A mid-sized biotechnology company operating in the EU faced critical pharmacovigilance (PV) compliance findings following an inspection by the European Medicines Agency and Medicines and Healthcare...
April 9, 2026
EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...